• 1. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 2. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 3. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 4. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 5. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459

Professional Introduction to 4-(Ethoxycarbonyl)-3-nitrobenzoic acid (CAS No. 87424-40-6)

4-(Ethoxycarbonyl)-3-nitrobenzoic acid, identified by the Chemical Abstracts Service Number (CAS No.) 87424-40-6, is a significant compound in the field of organic chemistry and pharmaceutical research. This compound belongs to the class of nitrobenzoic acids, characterized by the presence of both a nitro group and an ester functionality. The nitro group at the 3-position and the ethoxycarbonyl (acetoxy) group at the 4-position contribute to its unique reactivity and potential applications in synthetic chemistry and medicinal chemistry.

The structural features of 4-(Ethoxycarbonyl)-3-nitrobenzoic acid make it a valuable intermediate in the synthesis of more complex molecules. The nitro group, while being a strong electron-withdrawing substituent, can participate in various chemical transformations such as reduction to an amine or diazotization reactions. Meanwhile, the ethoxycarbonyl group can undergo hydrolysis to form a carboxylic acid or react with nucleophiles in esterification processes. These properties have made this compound a subject of interest in academic and industrial research.

In recent years, there has been growing interest in the applications of nitroaromatic compounds in drug discovery and development. The nitro group in 4-(Ethoxycarbonyl)-3-nitrobenzoic acid can be strategically incorporated into pharmacophores to modulate biological activity. For instance, nitroaromatics have been explored for their potential antimicrobial, antiviral, and anticancer properties. The ability to functionalize the aromatic ring further enhances its utility as a building block for drug candidates.

One of the most compelling aspects of 4-(Ethoxycarbonyl)-3-nitrobenzoic acid is its role in synthetic methodologies that enable the construction of heterocyclic structures. Heterocycles are prevalent in biologically active molecules, and their synthesis often requires specialized intermediates. The nitro and ester functionalities in this compound provide multiple points of intervention for synthetic chemists, allowing for the introduction of diverse substituents and the formation of complex molecular architectures.

Recent advancements in green chemistry have also highlighted the importance of sustainable synthetic routes. 4-(Ethoxycarbonyl)-3-nitrobenzoic acid can serve as a precursor in environmentally friendly synthetic protocols, where catalytic methods are employed to minimize waste and improve atom economy. Such approaches align with the broader goals of reducing the environmental impact of chemical synthesis while maintaining high yields and purity standards.

The pharmaceutical industry has shown particular interest in derivatives of benzoic acids due to their established biological activity. For example, substituted benzoic acids have been investigated for their potential as inhibitors of enzymes involved in inflammatory pathways. The presence of both a nitro group and an ester moiety in 4-(Ethoxycarbonyl)-3-nitrobenzoic acid suggests that it could be used to develop novel inhibitors or modulators targeting specific disease mechanisms.

In conclusion, 4-(Ethoxycarbonyl)-3-nitrobenzoic acid (CAS No. 87424-40-6) represents a versatile intermediate with significant potential in synthetic chemistry and pharmaceutical research. Its unique structural features enable diverse chemical transformations, making it a valuable tool for constructing complex molecules. As research continues to uncover new applications for nitroaromatic compounds, this compound is likely to remain a key player in drug discovery and development efforts aimed at addressing unmet medical needs.

• 5292-45-5(Dimethyl nitroterephthalate)
• 148625-35-8(methyl 3-formyl-4-nitro-benzoate)
• 16533-45-2(2-(Ethoxycarbonyl)-6-nitrobenzoic acid)
• 7356-11-8(Methyl 4-methyl-3-nitrobenzoate)
• 24078-21-5(Methyl 3-methyl-4-nitrobenzoate)
• 641-70-3(3-Nitrophthalic anhydride)
• 3816-62-4(Methyl 2-amino-5-nitrobenzoate)
• 30650-90-9(Ethyl 3-methyl-4-nitrobenzoate)
• 193014-01-6(Ethyl 3-amino-2-nitrobenzoate)
• 606-27-9(Methyl 2-nitrobenzoate)